Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study

BACKGROUND: Angiotensin-converting enzyme 2 facilitates the entry of severe acute respiratory syndrome coronavirus 2 into the human body. We investigated the association of renin-angiotensin-aldosterone system (RAAS) inhibitor use with severe coronavirus disease 2019 (COVID-19) outcomes in hypertens...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Jae Hyun, Choi, Sun Kyu, Kim, Nam Hoon, Lee, Juneyoung, Kim, Sin Gon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164940/
https://www.ncbi.nlm.nih.gov/pubmed/33611884
http://dx.doi.org/10.4093/dmj.2020.0279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164940/
https://www.ncbi.nlm.nih.gov/pubmed/33611884
http://dx.doi.org/10.4093/dmj.2020.0279

Ejemplares similares